Webcast ImageWebcast
Piper Jaffray 26th Annual Healthcare Conference (Live)
12/02/14 at 12:00 p.m. ET
Piper Jaffray 26th Annual Healthcare Conference
Tuesday, December 2, 2014 12:00 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

The field of oncology is evolving rapidly and transforming how cancer is treated. We believe Incyte, rooted in rigorous science, is at the center of this transformation. Our pipeline includes innovative compounds in three major oncology areas: onco-inflammation, immuno-oncology and targeted therapies.

We believe our professional and financial resources, our experience and our prior success in bringing important new drugs to market put us in a strong position to make a difference in health care, improve the lives of patients and build sustainable value for our shareholders.


Recent News More >>
DateTitle 
November 17, 2014Incyte to Present at Upcoming Investor Conferences
WILMINGTON, Del.--(BUSINESS WIRE)--Nov. 17, 2014-- Incyte Corporation (Nasdaq:INCY) announced today it will present at the following investor conferences during the month of December: Piper Jaffray 26th Annual Healthcare Conference on Tuesday, December 2, 2014 at 12:00 pm (EST) in New York; and Oppenheimer 25th Annual Healthcare Conference on Thursday, December 11, 2014 at 10:20 am (EST) in New York ... 
Printer Friendly Version
October 30, 2014Incyte Reports 2014 Third-Quarter Financial Results and Updates Shareholders on Key Clinical Programs
$97.8 million of 2014 third-quarter net product revenues from Jakafi® (ruxolitinib), representing 63 percent growth over the same period last year 2014 guidance for Jakafi net product revenues increased to range of $350 million to $360 million, driven by continued strong growth in underlying demand Two milestone payments from Novartis earned in the third quarter, totaling $85 million ... 
Printer Friendly Version
October 23, 2014Incyte to Present at the Nomura BioPharma Conference
WILMINGTON, Del.--(BUSINESS WIRE)--Oct. 23, 2014-- Incyte Corporation (Nasdaq:INCY) announced today it will present at the Nomura BioPharma Conference on Thursday, November 6, 2014 at 1:15 p.m. (EST) in Boston. The presentation will be webcast live and can be accessed at www.incyte.com under Investor Relations, Events and Webcasts. A replay of the presentation will be available. Investors interested in listening to the live webcast should ... 
Printer Friendly Version

2013 Annual Report
2013 Annual Report Download Documentation

2013 10-K

Notice To Readers: Incyte's press releases, presentations and printed remarks are included on this Web site for historical purposes only. The information contained in these documents and webcasts should be considered accurate only as of the date of the relevant document or presentation. This information may change over time; therefore, visitors to this Web site should not assume that the information contained in these documents or presentations remains accurate at a later time. We do not have any current intention, and expressly disclaim any obligation, to supplement, update or revise any of the information in these documents or presentations.


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.